AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3060967
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no antibiotic prophylaxis)
Trial: 2462383
Drug: 400 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 micrograms albuterol
Trial: 2462383
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg albuterol
Trial: 2462383
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg albuterol
Trial: 3511776
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg albuterol
Trial: 8061901
Drug: rIFN‐gamma 1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rIFN‐gamma 1.8 mg
Trial: 8061901
Drug: rIFN‐gamma 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rIFN‐gamma 0.2 mg and 0.6 mg
Trial: 3421209
Drug: control (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: control (18 vegetable-oil capsules)
Trial: 17168363
Drug: Focal radiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focal radiotherapy (20‐24 Gy) in accelerated hyperfractionation (1.3‐1.5 Gy, twice a day, at 5‐hr interval)
Trial: 8733683
Drug: 4 g/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g/m2 cyclophosphamide (CY)
Trial: 8733683
Drug: 7 g/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 g/m2 cyclophosphamide (CY)
Trial: 1929094
Drug: Povidone-iodine 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Povidone-iodine 5% preparation
Trial: 7075329
Drug: Father treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Father treatment
Trial: 7075329
Drug: Mother treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mother treatment
Trial: 7075329
Drug: Treatment (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment (both father and mother)
Trial: 31601449
Drug: Total nuts
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total nuts (10+ g/day)
Trial: 30672303
Drug: High-intensity laser
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity laser therapy + exercise therapy
Trial: 30672303
Drug: Sham-laser +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham-laser + exercise therapy
Trial: 26498439
Drug: Proton radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton radiation therapy (PRT)
Trial: 24368307
Drug: CNTF‐3 low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CNTF‐3 low-dose implant
Trial: 24368307
Drug: CNTF‐3 high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CNTF‐3 high-dose implant
Trial: 24368307
Drug: CNTF‐4 high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CNTF‐4 high-dose implant
Trial: 20883227
Drug: Lisinopril 40
RxNorm normalized name: lisinopril 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril 40 mg
Trial: 18974967
Drug: Lisinopril 60
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril 60 mg
Trial: 14725952
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg propoxyphene napsylate
Trial: 14725952
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg propoxyphene napsylate
Trial: 14725952
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg propoxyphene napsylate
Trial: 14725952
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg morphine sulfate
Trial: 11577993
Drug: (1‐‐>3)‐beta‐D‐glucan inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (1‐‐>3)‐beta‐D‐glucan inhalation
Trial: 28207540
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg mifepristone
Trial: 11360607
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg mifepristone plus 7.5 mg anordrin
Trial: 11360607
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg mifepristone plus 5 mg anordrin
Trial: 2278323
Drug: Midazolam 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.3 mg/kg, continuous infusion, with nitrous oxide in oxygen
Trial: 2278323
Drug: Midazolam 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.3 mg/kg, continuous infusion, with nitrous oxide in oxygen (600 ng/litre)
Trial: 2278323
Drug: Midazolam 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.3 mg/kg, continuous infusion, with oxygen in air (600 ng/litre)
Trial: 2278323
Drug: Nitrous oxide
RxNorm normalized name: Nitrous Oxide
DrugBank: Nitrous oxide (DB06690)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitrous oxide in combination with midazolam
Trial: 28987525
Drug: Trimethoprim-sulfamethoxazole (320/1,600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole (320/1,600 mg twice daily for 7 days)
Trial: 27465353
Drug: Local injection
RxNorm normalized name: Sclerosing agents for local injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local injection of adrenaline ± verapamil in the distal coronary bed through a perfusion balloon or selective microcatheter
Trial: 24105084
Drug: Embrace device
RxNorm normalized name: LANCET,EMBRACE DEVICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Embrace device treatment
Trial: 18188105
Drug: Intravenous ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ethanol infusion (EtOH)
Trial: 18188105
Drug: Scheduled-dose diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scheduled-dose diazepam (BENZO)
Trial: 11086638
Drug: Heparin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin infusion for at least 5 days
Trial: 1468246
Drug: Oral sulodexide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sulodexide (2 capsules of 250 lipoproteinolipase releasing units twice daily)
Trial: 1468246
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 identical capsules twice daily)
Trial: 6475654
Drug: Frusemide with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide with potassium supplements (48 mmol/day)
Trial: 6475654
Drug: Potassium-sparing diuretic
RxNorm normalized name: Potassium-sparing diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium-sparing diuretic
Trial: 3097108
Drug: Double-blind food
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-blind food challenge with lyophilized food in capsules or food mixed in broth
Trial: 3097108
Drug: Disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium cromoglycate (300 mg 30 minutes before food challenge)
Trial: 31023398
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment (three commonly prescribed antidepressants)
Trial: 30392345
Drug: Early enteral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early enteral nutrition (EEN) combined with parenteral nutrition (PN)
Trial: 22425474
Drug: Inpatient treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inpatient treatment based on cognitive behavior therapy for 4 weeks
Trial: 15778428
Drug: 1 mg/kg/week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg/week subcutaneous efalizumab for 12 weeks
Trial: 15778428
Drug: 2 mg/kg/week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg/week subcutaneous efalizumab for 12 weeks
Trial: 3968617
Drug: Supplementary calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplementary calcium to 21 mmol/L (Group B)
Trial: 3968617
Drug: Further calcium
RxNorm normalized name: HOMOSALATE 10 g in 100 mL / OCTOCRYLENE 7 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL LOTION [CO-BB-54431 Featuring You Hydrating Skin Enhancing Tint SPF30-270 FURTHER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Further calcium supplementation to 31.2 mmol/L (Group C)
Trial: 3968617
Drug: Milk with
RxNorm normalized name: BETTERMILK with Glytactin 10PE Powder for Suspension (Orange Creme)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk with calcium content 31.2 mmol/L and phosphorus supplementation to 15.7 mmol/L (Group D)
Trial: 24852701
Drug: Sildenafil 100
RxNorm normalized name: sildenafil 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 100 mg 1 hour before sexual intercourse
Trial: 21380565
Drug: Conventional temperature
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional temperature management using antipyretic medication and surface cooling (active control group)
Trial: 16353044
Drug: Atorvastatin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (10 mg/day, n=20)
Trial: 16353044
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg/day, n=18)
Trial: 8941005
Drug: Oral medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral medroxyprogesterone acetate (MPA) treatment at doses of 600, 800 or 1200 mg/day
Trial: 8941005
Drug: Oral medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral medroxyprogesterone acetate (MPA) treatment
Trial: 1338084
Drug: Hydrochlorothiazide +
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide + Amiloride (diuretic)
Trial: 1338084
Drug: Supplementary treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplementary treatment (beta-blocker to diuretic, or vice versa)
Trial: 1338084
Drug: All active
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All active treatment regimens
Trial: 6372360
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg PGE2 pessary
Trial: 6372360
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg PGE2 pessary
Trial: 6372360
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg PGE2 pessary
Trial: 25786769
Drug: Esomeprazole 20
RxNorm normalized name: esomeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 20 mg q.d.
Trial: 25786769
Drug: Esomeprazole 10
RxNorm normalized name: esomeprazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 10 mg q.d.
Trial: 21999631
Drug: Nevirapine (NVP)
RxNorm normalized name: Nevirapine
DrugBank: Nevirapine (DB00238)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nevirapine (NVP) 200 mg twice daily
Trial: 21999631
Drug: Ritonavir-boosted atazanavir
RxNorm normalized name: atazanavir and ritonavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir-boosted atazanavir (ATV/r) 300/100 mg once daily
Trial: 18456465
Drug: Azithromycin extended
RxNorm normalized name: azithromycin Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin extended release (AZ‐ER) 2g single dose
Trial: 18456465
Drug: Azithromycin immediate
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin immediate release (AZ‐IR) 500mg daily for 3 days
Trial: 9186076
Drug: Lisinopril (n
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lisinopril (n = 13)
Trial: 9488243
Drug: Nifedipine GITS
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine GITS and Lisinopril
Trial: 8108538
Drug: Intra-articular steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular steroids
Trial: 23742737
Drug: nabiximols (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nabiximols (oral mucosal spray containing cannabinoids)
Trial: 16636857
Drug: Sublingual androstenediol
RxNorm normalized name: androstenedione
DrugBank: Androstenedione (DB01536)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual androstenediol (SL-DIOL) with exercise (EX)
Trial: 16636857
Drug: Sublingual androstenediol
RxNorm normalized name: androstenedione
DrugBank: Androstenedione (DB01536)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual androstenediol (SL-DIOL) without exercise (Rest)
Trial: 16636857
Drug: Sublingual androstenediol
RxNorm normalized name: androstenedione
DrugBank: Androstenedione (DB01536)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual androstenediol (SL-DIOL)
Trial: 9005501
Drug: IHB before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IHB before incision using 0.25 ml/kg bupivacaine 0.5%
Trial: 9005501
Drug: IHB after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IHB after incision using 0.25 ml/kg bupivacaine 0.5%
Trial: 9005501
Drug: IHB before
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IHB before incision with 0.25 ml/kg of serum
Trial: 9005501
Drug: IHB after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IHB after incision with 0.25 ml/kg of serum
Trial: 8151594
Drug: Misoprostol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol (400 micrograms oral dose)
Trial: 29480182
Drug: Sequential memory
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sequential memory training after stationary cycling (SEQ)
Trial: 28199799
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g protein hydrolysate
Trial: 21381272
Drug: Various treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various treatment options
Trial: 2773628
Drug: Ranitidine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (50 mg)
Trial: 391625
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of oxprenolol 80 mg + chlorthalidone 10 mg given once daily
Trial: 391625
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of oxprenolol 80 mg + chlorthalidone 10 mg given b.i.d.
Trial: 31610616
Drug: Gabapentin 600
RxNorm normalized name: gabapentin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 600 mg oral, 1 hour preprocedure
Trial: 30298469
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus cisplatin (GC) as first-line chemotherapy
Trial: 30298469
Drug: Validation dataset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Validation dataset of patients receiving GC therapy
Trial: 18431091
Drug: Ergocalciferol 50,000
RxNorm normalized name: ergocalciferol 50,000 intl units oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ergocalciferol 50,000 IU once weekly for 3 months
Trial: 14681961
Drug: Pronoran (piribedil)
RxNorm normalized name: piribedil
DrugBank: Piribedil (DB12478)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pronoran (piribedil) combined with levodopa, dosage 50-150 mg daily for 6 months
Trial: 7029740
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of metoprolol tartrate 100 mg and chlorthalidone 25 mg
Trial: 2270941
Drug: Lente insulin
RxNorm normalized name: lente insulin, pork
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lente insulin
Trial: 24942594
Drug: 0.2% E6005
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2% E6005 ointment
Trial: 18083473
Drug: Preoperative intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative intravenous (IV) 50 mg flurbiprofen (group F)
Trial: 16216607
Drug: Magnetocardiography (MCG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnetocardiography (MCG) at 40 Hz
Trial: 16216607
Drug: Magnetocardiography (MCG)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnetocardiography (MCG) for root mean square of the last 40 milliseconds of atrial signal
Trial: 29518425
Drug: Montelukast (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast (20 mg twice daily)
Trial: 29518425
Drug: LTE4 inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTE4 inhalation
Trial: 24281911
Drug: Flavor-matched placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavor-matched placebo administered 30 minutes before exercise (P30)
Trial: 24281911
Drug: Flavor-matched placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavor-matched placebo administered 120 minutes before exercise (P120)
Trial: 24281911
Drug: 2% carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% carbohydrate solution ingested 30 minutes before exercise
Trial: 24281911
Drug: 0% carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0% carbohydrate solution ingested 30 minutes before exercise
Trial: 24281911
Drug: 12% carbohydrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12% carbohydrate solution ingested 30 minutes before exercise
Trial: 15839797
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg cortisol
Trial: 12887481
Drug: 320 mg
RxNorm normalized name: aspirin 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 320 mg S. repens extract
Trial: 10485422
Drug: Heparin-bonded (Carmeda)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-bonded (Carmeda) circuits
Trial: 1938849
Drug: Verapamil 40
RxNorm normalized name: verapamil 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 40 mg
Trial: 3044425
Drug: Verapamil 80
RxNorm normalized name: verapamil 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 80 mg
Trial: 31923193
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (50 ?g every four hours as needed)
Trial: 31923193
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose vaginal misoprostol (25 to 50 ?g every six hours as needed)
Trial: 31923193
Drug: Vaginal dinoprostone
RxNorm normalized name: dinoprostone Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal dinoprostone (one to two mg every six hours as needed)
Trial: 15777441
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose vaginal misoprostol
Trial: 31085679
Drug: Nicotinamide (NAM)
DrugBank: Nicotinamide (DB02701)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotinamide (NAM) 750 mg twice daily plus Lanthanum Carbonate (LC) 1000 mg thrice daily
Trial: 29281192
Drug: Dried salted
RxNorm normalized name: peptone,dried
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dried salted plum consumption during HBO₂ therapy
Trial: 26350942
Drug: Alternating arm
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternating arm motion 30 Hz low amplitude WBV (Alt_30 Hz-L)
Trial: 26350942
Drug: Double arm
RxNorm normalized name: ARM-210
DrugBank: ARM-210 (DB16944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double arm motion 30Hz low amplitude WBV (Double_30Hz-L)
Trial: 25398689
Drug: Abediterol 0.313
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abediterol 0.313 μg
Trial: 27439370
Drug: Abediterol 0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abediterol 0.625 μg
Trial: 25398689
Drug: Abediterol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abediterol 1.25 μg
Trial: 27439370
Drug: Abediterol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abediterol 2.5 μg
Trial: 25398689
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of Abediterol
Trial: 22260858
Drug: Doenjang (9.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doenjang (9.9 g/d for 12 weeks)
Trial: 17927645
Drug: Telephone-administered behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-administered behavioral migraine management program (TAT)
Trial: 17927645
Drug: Standard Triptan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Triptan Treatment (TT)
Trial: 15375787
Drug: 20 mg/d
RxNorm normalized name: Valtoco, 20 mg/dose nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/d Wheat germ policosanol (WGP) for 4 weeks
Trial: 9733054
Drug: rhIL-2, 9000000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhIL-2, 9000000 IU subcutaneously twice daily for 3 days before surgery
Trial: 9733054
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no rhIL-2 administration)
Trial: 7984740
Drug: In-home therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-home therapy program (6 weeks)
Trial: 7984740
Drug: Traditional county
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional county services (no in-home therapy)
Trial: 2725163
Drug: Systemic treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic treatment (antimicrobial chemotherapeutic agents)